Pfam Domains GO Terms
| Homeobox |
| negative regulation of T-helper 2 cell differentiation |
| positive regulation of T-helper 1 cell differentiation |
| regulation of T-helper 1 cell differentiation |
| regulation of T-helper 2 cell differentiation |
| enteric nervous system development |
| negative regulation of type 2 immune response |
| negative regulation of T-helper cell differentiation |
| embryonic digestive tract morphogenesis |
| positive regulation of T-helper 1 type immune response |
| negative regulation of CD4-positive, alpha-beta T cell differentiation |
| positive regulation of T-helper cell differentiation |
| negative regulation of alpha-beta T cell differentiation |
| regulation of T-helper 1 type immune response |
| negative regulation of CD4-positive, alpha-beta T cell activation |
| positive regulation of CD4-positive, alpha-beta T cell differentiation |
| regulation of type 2 immune response |
| positive regulation of CD4-positive, alpha-beta T cell activation |
| regulation of T-helper cell differentiation |
| embryonic digestive tract development |
| negative regulation of alpha-beta T cell activation |
| negative regulation of T cell differentiation |
| autonomic nervous system development |
| positive regulation of alpha-beta T cell differentiation |
| regulation of CD4-positive, alpha-beta T cell differentiation |
| digestive tract morphogenesis |
| positive regulation of organ growth |
| negative regulation of lymphocyte differentiation |
| positive regulation of alpha-beta T cell activation |
| regulation of CD4-positive, alpha-beta T cell activation |
| regulation of alpha-beta T cell differentiation |
| positive regulation of T cell differentiation |
| regulation of alpha-beta T cell activation |
| positive regulation of lymphocyte differentiation |
| regulation of organ growth |
| negative regulation of leukocyte differentiation |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| positive regulation of adaptive immune response |
| negative regulation of T cell activation |
| negative regulation of immune effector process |
| negative regulation of leukocyte cell-cell adhesion |
| skeletal muscle tissue development |
| liver development |
| hepaticobiliary system development |
| digestive tract development |
| skeletal muscle organ development |
| negative regulation of hemopoiesis |
| regulation of T cell differentiation |
| digestive system development |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| negative regulation of lymphocyte activation |
| positive regulation of leukocyte differentiation |
| negative regulation of immune response |
| regulation of adaptive immune response |
| regulation of lymphocyte differentiation |
| positive regulation of developmental growth |
| negative regulation of cell-cell adhesion |
| negative regulation of leukocyte activation |
| positive regulation of hemopoiesis |
| negative regulation of cell activation |
| positive regulation of T cell activation |
| positive regulation of leukocyte cell-cell adhesion |
| positive regulation of immune effector process |
| positive regulation of cell-cell adhesion |
| positive regulation of growth |
| regulation of leukocyte differentiation |
| negative regulation of cell adhesion |
| striated muscle tissue development |
| embryonic organ morphogenesis |
| muscle organ development |
| regulation of leukocyte cell-cell adhesion |
| muscle tissue development |
| regulation of T cell activation |
| regulation of developmental growth |
| positive regulation of lymphocyte activation |
| regulation of cell-cell adhesion |
| positive regulation of cell adhesion |
| positive regulation of leukocyte activation |
| gland development |
| positive regulation of cell activation |
| sequence-specific DNA binding |
| embryonic organ development |
| negative regulation of immune system process |
| regulation of hemopoiesis |
| regulation of immune effector process |
| muscle structure development |
| regulation of lymphocyte activation |
| embryonic morphogenesis |
| regulation of leukocyte activation |
| regulation of cell activation |
| tube morphogenesis |
| regulation of growth |
| regulation of cell adhesion |
| negative regulation of cell differentiation |
| tube development |
| positive regulation of immune response |
| positive regulation of cell population proliferation |
| negative regulation of developmental process |
| animal organ morphogenesis |
| positive regulation of cell differentiation |
| embryo development |
| positive regulation of immune system process |
| regulation of immune response |
| negative regulation of multicellular organismal process |
| positive regulation of developmental process |
| DNA-binding transcription factor activity, RNA polymerase II-specific |
| regulation of cell population proliferation |
| negative regulation of response to stimulus |
| regulation of immune system process |
| positive regulation of multicellular organismal process |
| tissue development |
| regulation of cell differentiation |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution